Skip to main content
Erschienen in: Inflammation 3/2013

01.06.2013

Association of Body Fat with Inflammation in Peritoneal Dialysis

verfasst von: Andresa Marques de Mattos, Paula Payão Ovidio, Alceu Afonso Jordão, José Abrão Cardeal da Costa, Paula Garcia Chiarello

Erschienen in: Inflammation | Ausgabe 3/2013

Einloggen, um Zugang zu erhalten

Abstract

Peritoneal dialysis (PD) frequently leads to body weight gain, which appears to be a potential cause of the chronic inflammation frequently present in these patients. The consequences of this inflammation are impaired nutritional status, accelerated atherosclerosis, and increased mortality. To assess the association between inflammation and body fat in female patients treated with PD. Nineteen female patients on PD for at least 6 months with no infectious complications or malignant or acute inflammatory diseases. Nutritional status was determined by measuring weight, height, body mass index (BMI), waist (WC), and mid-arm circumferences (MAC), mid-arm muscle area, and tricipital fold (TCF). Bioelectrical impedance (BIA) was used to determine body composition. Biochemical evaluation included the determination of serum albumin, urea, creatinine, and C-reactive protein (CRP). The glucose absorbed from the dialysis solution was quantitated. According to BMI, two patients were classified as malnourished and ten as overweight/obese. Sixteen individuals had high WC measurements and 12 had excess body fat (BF) as measured by BIA. High CRP levels were observed in 12 patients, who had higher WC, MAC, BMI, TCF, and BF measurements compared to non-inflamed patients. Positive associations were detected between CRP and BMI, MAC, WC, and TCF. Associations between BF and CRP suggest that adiposity may be a potent exacerbating factor of inflammation in this population, especially visceral fat. Thus, obesity may be considered to be one more factor responsible for the early atherosclerosis and high cardiovascular mortality observed in these patients.
Literatur
1.
Zurück zum Zitat Carvalho, L.K., M.I.B. Silva, B.S. Vale, R. Bregman, R.B. Martucci, J.J. Carerro, et al. 2011. Annual variation in body fat is associated with systemic inflammation in chronic kidney disease patients stages 3 and 4: a longitudinal study. Nephrology Dialysis Transplantation 0: 1–6. Carvalho, L.K., M.I.B. Silva, B.S. Vale, R. Bregman, R.B. Martucci, J.J. Carerro, et al. 2011. Annual variation in body fat is associated with systemic inflammation in chronic kidney disease patients stages 3 and 4: a longitudinal study. Nephrology Dialysis Transplantation 0: 1–6.
2.
Zurück zum Zitat Axelsson, J., A.R. Qureshi, M.E. Suliman, H. Honda, R. Pecoits-Filho, O. Heimbürger, et al. 2004. Truncal fat mass as a contributor to inflammation in end-stage renal disease. The American Journal of Clinical Nutrition 80: 1222–1229.PubMed Axelsson, J., A.R. Qureshi, M.E. Suliman, H. Honda, R. Pecoits-Filho, O. Heimbürger, et al. 2004. Truncal fat mass as a contributor to inflammation in end-stage renal disease. The American Journal of Clinical Nutrition 80: 1222–1229.PubMed
3.
Zurück zum Zitat Lai, K.N., and J.C.K. Leung. 2010. Inflammation in peritoneal dialysis. Nephron Clinical Practice 116: 11–18.CrossRef Lai, K.N., and J.C.K. Leung. 2010. Inflammation in peritoneal dialysis. Nephron Clinical Practice 116: 11–18.CrossRef
4.
Zurück zum Zitat Lai, K.N., and J.C.K. Leung. 2010. Peritoneal adipocytes and their role in inflammation during peritoneal dialysis. Mediators of Inflammation 2010: 1–10.CrossRef Lai, K.N., and J.C.K. Leung. 2010. Peritoneal adipocytes and their role in inflammation during peritoneal dialysis. Mediators of Inflammation 2010: 1–10.CrossRef
5.
Zurück zum Zitat Nihi, M.M., R.C. Manfro, C. Martins, M. Suliman, Y. Murayama, M.C. Riella, et al. 2010. Association between body fat, inflammation and oxidative stress in hemodialysis. Jornal Brasileiro de Nefrologia 32(1): 11–17.CrossRef Nihi, M.M., R.C. Manfro, C. Martins, M. Suliman, Y. Murayama, M.C. Riella, et al. 2010. Association between body fat, inflammation and oxidative stress in hemodialysis. Jornal Brasileiro de Nefrologia 32(1): 11–17.CrossRef
6.
Zurück zum Zitat Ramos, L.F., A. Shintani, T.A. Ikizler, and J. Himmelfarb. 2008. Oxidative stress and inflammation are associated with adiposity in moderate to severe CKD. Journal of the American Society of Nephrology 19: 593–599.PubMedCrossRef Ramos, L.F., A. Shintani, T.A. Ikizler, and J. Himmelfarb. 2008. Oxidative stress and inflammation are associated with adiposity in moderate to severe CKD. Journal of the American Society of Nephrology 19: 593–599.PubMedCrossRef
7.
Zurück zum Zitat Kaysen, G.A., P. Kotanko, F. Zhu, S.R. Sarkar, S.B. Heymsfield, M.K. Kuhlmann, et al. 2009. Relationship between adiposity and cardiovascular risk factors in prevalent hemodialysis patients. Journal of Renal Nutrition 19(5): 357–364.PubMedCrossRef Kaysen, G.A., P. Kotanko, F. Zhu, S.R. Sarkar, S.B. Heymsfield, M.K. Kuhlmann, et al. 2009. Relationship between adiposity and cardiovascular risk factors in prevalent hemodialysis patients. Journal of Renal Nutrition 19(5): 357–364.PubMedCrossRef
8.
Zurück zum Zitat Berbel, M.N., M.P.R. Pinto, D. Ponce, and A.L. Balbi. 2011. Nutritional aspects in acute kidney injury. Revista da Associação Médica Brasileira 57(5): 587–592.CrossRef Berbel, M.N., M.P.R. Pinto, D. Ponce, and A.L. Balbi. 2011. Nutritional aspects in acute kidney injury. Revista da Associação Médica Brasileira 57(5): 587–592.CrossRef
9.
Zurück zum Zitat Kamimura, M.A., S.A. Draibe, D.M. Sigulem, and L. Cuppari. 2004. Methods of body composition assessment in patients undergoing hemodialysis. Revista de Nutrição 17(1): 97–105.CrossRef Kamimura, M.A., S.A. Draibe, D.M. Sigulem, and L. Cuppari. 2004. Methods of body composition assessment in patients undergoing hemodialysis. Revista de Nutrição 17(1): 97–105.CrossRef
10.
Zurück zum Zitat Lipschitz, D.A. 1994. Screening for nutritional status in the elderly. Primary Care 21(1): 55–67.PubMed Lipschitz, D.A. 1994. Screening for nutritional status in the elderly. Primary Care 21(1): 55–67.PubMed
11.
Zurück zum Zitat Frisancho, A.R. 1981. New norms of upper limb fat and muscle areas for assessment of nutritional status. The American Journal of Clinical Nutrition 34: 2540–2545.PubMed Frisancho, A.R. 1981. New norms of upper limb fat and muscle areas for assessment of nutritional status. The American Journal of Clinical Nutrition 34: 2540–2545.PubMed
12.
Zurück zum Zitat Heyward, V.H., and D.R. Wagner. 2004. Applied body composition assessment, 2nd ed. Champaign: Human Kinetics. Heyward, V.H., and D.R. Wagner. 2004. Applied body composition assessment, 2nd ed. Champaign: Human Kinetics.
13.
Zurück zum Zitat National Kidney Foundation. 2000. K/DOQI clinical practice guidelines for nutrition in chronic renal failure. American Journal of Kidney Diseases 35(6): 1–3.CrossRef National Kidney Foundation. 2000. K/DOQI clinical practice guidelines for nutrition in chronic renal failure. American Journal of Kidney Diseases 35(6): 1–3.CrossRef
14.
Zurück zum Zitat Daugirdas JT. 1994. Prescrição de hemodiálise crônica: Uma abordagem da cinética da uréia, 86–113 Mesi, Belo Horizonte, Brasil Daugirdas JT. 1994. Prescrição de hemodiálise crônica: Uma abordagem da cinética da uréia, 86–113 Mesi, Belo Horizonte, Brasil
15.
Zurück zum Zitat National Kidney Foundation. 1997. K/DOQI clinical practice guidelines for peritoneal dialysis adequacy. American Journal of Kidney Diseases 30: 67–136.CrossRef National Kidney Foundation. 1997. K/DOQI clinical practice guidelines for peritoneal dialysis adequacy. American Journal of Kidney Diseases 30: 67–136.CrossRef
16.
Zurück zum Zitat Nascimento, M.M., R. Pecoits-Filho, A.R. Qureshi, et al. 2004. The prognostic impact of fluctuating levels of C-reactive protein in Brazilian haemodialysis patients: a prospective study. Nephrology Dialysis Transplantation 19: 2803–2809.CrossRef Nascimento, M.M., R. Pecoits-Filho, A.R. Qureshi, et al. 2004. The prognostic impact of fluctuating levels of C-reactive protein in Brazilian haemodialysis patients: a prospective study. Nephrology Dialysis Transplantation 19: 2803–2809.CrossRef
17.
Zurück zum Zitat SAS/STAT® User’s Guide, Version 9.0, Cary, NC, USA: SAS Institute Inc., 2002. SAS/STAT® User’s Guide, Version 9.0, Cary, NC, USA: SAS Institute Inc., 2002.
18.
Zurück zum Zitat Chow, V.C., R.M. Yong, A.L. Li, C.W. Lee, E.H. Ho, C.K. Chan, et al. 2003. Nutritional requirements and actual dietary intake of continuous ambulatory peritoneal dialysis patients. Peritoneal Dialysis International 23(S2): 52–54. Chow, V.C., R.M. Yong, A.L. Li, C.W. Lee, E.H. Ho, C.K. Chan, et al. 2003. Nutritional requirements and actual dietary intake of continuous ambulatory peritoneal dialysis patients. Peritoneal Dialysis International 23(S2): 52–54.
19.
Zurück zum Zitat Johnson, D.W. 2007. What is the optimal fat mass in peritoneal dialysis patients? Peritoneal Dialysis International 27(S2): 250–254. Johnson, D.W. 2007. What is the optimal fat mass in peritoneal dialysis patients? Peritoneal Dialysis International 27(S2): 250–254.
20.
Zurück zum Zitat Wankowicz, Z. 2009. Peritoneal dialysis and its role in the demography and epidemiology of chronic kidney disease. Polskie Archiwun Medycyny Wewnetrznej 119(12): 810–813. Wankowicz, Z. 2009. Peritoneal dialysis and its role in the demography and epidemiology of chronic kidney disease. Polskie Archiwun Medycyny Wewnetrznej 119(12): 810–813.
21.
Zurück zum Zitat Park, S.H., and B. Lindholm. 2009. Definition of metabolic syndrome in peritoneal dialysis. Peritoneal Dialysis International 29(S2): 137–144. Park, S.H., and B. Lindholm. 2009. Definition of metabolic syndrome in peritoneal dialysis. Peritoneal Dialysis International 29(S2): 137–144.
22.
Zurück zum Zitat Di Gioia, M.C., P. Gallar, I. Rodriguez, N. Laso, R. Callejas, and Ortega. 2012. Changes in body composition parameters in patients on haemodialysis and peritoneal dialysis. Nefrología 32(1): 108–113. Di Gioia, M.C., P. Gallar, I. Rodriguez, N. Laso, R. Callejas, and Ortega. 2012. Changes in body composition parameters in patients on haemodialysis and peritoneal dialysis. Nefrología 32(1): 108–113.
23.
Zurück zum Zitat Su, W.S., C.M. Clase, K.S. Brimble, P.J. Margetts, T.J. Wilkieson, and A.S. Gangji. 2010. Waist-to-hip ratio, cardiovascular outcomes, and death in peritoneal dialysis patients. The International Journal of Pediatric Nephrology 2010: 1–5.CrossRef Su, W.S., C.M. Clase, K.S. Brimble, P.J. Margetts, T.J. Wilkieson, and A.S. Gangji. 2010. Waist-to-hip ratio, cardiovascular outcomes, and death in peritoneal dialysis patients. The International Journal of Pediatric Nephrology 2010: 1–5.CrossRef
24.
Zurück zum Zitat Wang, X., J. Axelsson, L. Nordfors, A. Rashid Quresh, C. Avesani, P. Barany, et al. 2007. Changes in fat mass after initiation of maintenance dialysis is influenced by the uncoupling protein 2 exon 8 insertion/deletion polymorphism. Nephrology, Dialysis, Transplantation 22: 196–202.PubMedCrossRef Wang, X., J. Axelsson, L. Nordfors, A. Rashid Quresh, C. Avesani, P. Barany, et al. 2007. Changes in fat mass after initiation of maintenance dialysis is influenced by the uncoupling protein 2 exon 8 insertion/deletion polymorphism. Nephrology, Dialysis, Transplantation 22: 196–202.PubMedCrossRef
25.
Zurück zum Zitat Dummer, C.D., F.S. Thomé, and F.V. Veronese. 2007. Doença renal crônica, inflamação e aterosclerose: novos conceitos de um velho problema. Revista da Associação Médica Brasileira 53: 446–450.PubMedCrossRef Dummer, C.D., F.S. Thomé, and F.V. Veronese. 2007. Doença renal crônica, inflamação e aterosclerose: novos conceitos de um velho problema. Revista da Associação Médica Brasileira 53: 446–450.PubMedCrossRef
26.
Zurück zum Zitat Nascimento, M.M., M.E. Suliman, M. Silva, et al. 2010. Effect of oral N-acetylcysteine treatment on plasma inflammatory and oxidative stress markers in peritoneal dialysis patients: a placebo-controlled study. Peritoneal Dialysis International 30: 336–342.PubMedCrossRef Nascimento, M.M., M.E. Suliman, M. Silva, et al. 2010. Effect of oral N-acetylcysteine treatment on plasma inflammatory and oxidative stress markers in peritoneal dialysis patients: a placebo-controlled study. Peritoneal Dialysis International 30: 336–342.PubMedCrossRef
27.
Zurück zum Zitat Witasp, A., J.J. Carrero, O. Heimbürger, B. Lindholm, F. Hammarqviso, P. Stenvinkel, et al. 2011. Increased expression of pro-inflammatory genes in abdominal subcutaneous fat in advanced chronic kidney disease patients. Internal Medicine 269: 410–419.CrossRef Witasp, A., J.J. Carrero, O. Heimbürger, B. Lindholm, F. Hammarqviso, P. Stenvinkel, et al. 2011. Increased expression of pro-inflammatory genes in abdominal subcutaneous fat in advanced chronic kidney disease patients. Internal Medicine 269: 410–419.CrossRef
Metadaten
Titel
Association of Body Fat with Inflammation in Peritoneal Dialysis
verfasst von
Andresa Marques de Mattos
Paula Payão Ovidio
Alceu Afonso Jordão
José Abrão Cardeal da Costa
Paula Garcia Chiarello
Publikationsdatum
01.06.2013
Verlag
Springer US
Erschienen in
Inflammation / Ausgabe 3/2013
Print ISSN: 0360-3997
Elektronische ISSN: 1573-2576
DOI
https://doi.org/10.1007/s10753-013-9593-3

Weitere Artikel der Ausgabe 3/2013

Inflammation 3/2013 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.